• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者报告症状影响量表(PRISS):编制与验证。

Patient-reported impact of symptoms in schizophrenia scale (PRISS): Development and validation.

机构信息

Department of Personality, Assessment and Psychological Treatment, University of Malaga, Malaga, Spain.

Andalusian Group of Psychosocial Research (GAP), Andalucía, Spain.

出版信息

Acta Psychiatr Scand. 2022 Jun;145(6):640-655. doi: 10.1111/acps.13417. Epub 2022 Mar 2.

DOI:10.1111/acps.13417
PMID:35188673
Abstract

BACKGROUND

We report the psychometric properties of the Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS), which assesses the impact of subjective experiences or qualia in outpatients with this condition.

METHODS

A cross-sectional study was carried out in 162 patients diagnosed with schizophrenia in Spain. The PRISS measures the presence, frequency, concern and interference with daily life of self-reported experiences related to the main symptoms observed in these patients. The psychometric analysis included test-retest reliability, internal consistency and structural and convergent validity.

RESULTS

The 28-item PRISS showed good test-retest reliability as 64.3% of the intraclass correlation coefficient values were between 0.40 and 0.79, which were statistically significant (p < 0.01). Analysis of the structural validity revealed a three-factor structure, (1) productive subjective experiences, (2) affective-negative subjective experiences and (3) excitation, which accounted for 56.11% of the variance. Of the Pearson's correlation coefficients analysed between the PRISS and the Positive and Negative Syndrome Scale (PANSS), Scale for Assessment of Negative Symptoms (SANS) and World Health Organization Disability Assessment Schedule (WHO-DAS), 72.2% were statistically significant (p < 0.05) and ranged from 0.38-0.42, 0.32-0.42 and 0.40-0.42, respectively.

CONCLUSION

Our results indicate that the PRISS appears to be a brief, reliable and valid scale to measure subjective experiences in schizophrenia and provides valuable information complementary to clinical evaluation.

摘要

背景

我们报告了精神分裂症患者报告的症状影响量表(PRISS)的心理测量特性,该量表评估了这种情况下门诊患者主观体验或质的影响。

方法

在西班牙对 162 名被诊断为精神分裂症的患者进行了横断面研究。PRISS 测量了与这些患者观察到的主要症状相关的自我报告体验的存在、频率、关注和对日常生活的干扰。心理测量分析包括重测信度、内部一致性以及结构和收敛效度。

结果

28 项 PRISS 表现出良好的重测信度,因为 64.3%的组内相关系数值在 0.40 到 0.79 之间,具有统计学意义(p<0.01)。结构有效性分析显示出三因素结构,(1)生产性主观体验,(2)情感-消极主观体验和(3)兴奋,这三个因素占方差的 56.11%。在 PRISS 与阳性和阴性综合征量表(PANSS)、负面症状评定量表(SANS)和世界卫生组织残疾评估量表(WHO-DAS)之间分析的皮尔逊相关系数中,72.2%具有统计学意义(p<0.05),范围从 0.38 到 0.42,0.32 到 0.42 和 0.40 到 0.42。

结论

我们的结果表明,PRISS 似乎是一种简短、可靠和有效的量表,可以衡量精神分裂症患者的主观体验,并提供对临床评估有价值的补充信息。

相似文献

1
Patient-reported impact of symptoms in schizophrenia scale (PRISS): Development and validation.精神分裂症患者报告症状影响量表(PRISS):编制与验证。
Acta Psychiatr Scand. 2022 Jun;145(6):640-655. doi: 10.1111/acps.13417. Epub 2022 Mar 2.
2
Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale.中文版精神分裂症患者症状影响报告量表的效度和信度检验
Front Psychiatry. 2023 May 24;14:1158937. doi: 10.3389/fpsyt.2023.1158937. eCollection 2023.
3
Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.验证《精神分裂症患者阴性症状自评量表(SNS)》的西班牙语版(欧洲)。
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Jan-Mar;15(1):14-21. doi: 10.1016/j.rpsmen.2022.01.005.
4
Validation and reliability testing of the Breast-Q latissimus dorsi questionnaire: cross-cultural adaptation and psychometric properties in a Swedish population.验证和可靠性测试的乳房-Q 背阔肌问卷:跨文化适应和心理测量特性在瑞典人群。
Health Qual Life Outcomes. 2021 Jul 3;19(1):174. doi: 10.1186/s12955-021-01812-x.
5
A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).一种用于精神病症状领域的新简短评定量表的效度和信度的初步检验:精神病症状领域简短评估(BE-PSD)。
J Psychiatr Res. 2016 Sep;80:87-92. doi: 10.1016/j.jpsychires.2016.06.005. Epub 2016 Jun 8.
6
Development and psychometric properties of a new brief scale for subjective personal agency (SPA-5) in people with schizophrenia.主观个人能动性新简式量表(SPA-5)在精神分裂症患者中的编制及心理测量学特性研究。
Epidemiol Psychiatr Sci. 2020 Apr 10;29:e111. doi: 10.1017/S2045796020000256.
7
Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire.颅面疼痛与功能障碍量表(CF-PDI):一种新问卷的编制及心理测量学验证
Pain Physician. 2014 Jan-Feb;17(1):95-108.
8
Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.阴性症状评估量表 -16(NSA - 16)在西班牙精神分裂症患者中的有效性验证
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Jul-Sep;11(3):169-175. doi: 10.1016/j.rpsm.2018.03.001. Epub 2018 Apr 5.
9
The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) questionnaire. A validation study with Spanish schizophrenia spectrum outpatients.精神分裂症生活质量量表修订版4(SQLS-R4)问卷。一项针对西班牙精神分裂症谱系门诊患者的效度研究。
Actas Esp Psiquiatr. 2019 May;47(3):97-109. Epub 2019 May 1.
10
Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity.使用临床医生和患者报告的测量方法衡量精神分裂症的负担:对构念效度的探索性分析。
Patient. 2019 Aug;12(4):405-417. doi: 10.1007/s40271-019-00358-x.

引用本文的文献

1
The causal relationship between six mental disorders and breast cancer risk: A two-sample Mendelian randomization study.六种精神障碍与乳腺癌风险之间的因果关系:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Apr 18;104(16):e42209. doi: 10.1097/MD.0000000000042209.
2
Intervention control of aerobic exercise in maintaining quality of life and pulmonary hypertension in hemodialysis patients.有氧运动干预对维持血液透析患者生活质量及控制肺动脉高压的作用
World J Clin Cases. 2024 Jul 16;12(20):4217-4229. doi: 10.12998/wjcc.v12.i20.4217.
3
Sex differences in patient-reported outcome measure of psychotic symptoms in schizophrenia.
精神分裂症患者报告的精神病症状的患者报告结局测量中的性别差异。
Arch Womens Ment Health. 2024 Oct;27(5):721-729. doi: 10.1007/s00737-024-01472-y. Epub 2024 Jun 5.
4
Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale.中文版精神分裂症患者症状影响报告量表的效度和信度检验
Front Psychiatry. 2023 May 24;14:1158937. doi: 10.3389/fpsyt.2023.1158937. eCollection 2023.